Cornerstone Robotics Partners with Medtronic to Enhance Global Access to Robotic Surgery
In a strategic announcement made recently, Cornerstone Robotics, a pioneering surgical robotics firm based in Hong Kong, has forged a partnership with Medtronic, a global leader in medical technology. This collaboration aims to significantly enhance global access to robotic-assisted surgeries, a crucial step in bridging the existing gap in healthcare delivery.
The partnership features a substantial investment of approximately $700 million from Medtronic in Cornerstone Robotics, granting Medtronic distribution rights for Cornerstone's revolutionary surgical system, the Sentire™, across select international markets outside the United States where the system is approved. This development is designed to provide more surgical options and improve surgical outcomes for a broader population around the world.
Currently, only a minuscule percentage of surgeries around the globe utilize robotic systems. Cornerstone Robotics and Medtronic share a unified vision to decrease this gap significantly by expanding the reach of their innovative surgical solutions to numerous healthcare providers and patients in need. This mission is not only about technological advancement but also about addressing a pressing global health challenge—the accessibility of minimally invasive surgical care.
To achieve this goal, it is essential for both companies to leverage continuous technical innovations and scalable market strategies. Combining Cornerstone's cutting-edge robotics technology with Medtronic's expansive global network positions them uniquely to usher in a new era of high-quality robotic surgery accessible to a larger patient demographic.
Cornerstone Robotics has established solid foundations built on extensive research and development, integrating various technological stacks while employing a vertically integrated operational model. The company designs and manufactures essential hardware, control software, advanced algorithms, and proprietary imaging and energy platforms. This meticulous approach allows Cornerstone to maintain significant control over product integration, quality assurance, and supply chain resilience, crucial for the precise operation of the Sentire surgical system in demanding clinical environments.
As of 2024, the Sentire surgical system received approval from the National Medical Products Administration in China. Furthermore, in May 2026, the system attained CE marking status in the European Union and received validation from the Health Sciences Authority in Singapore. These endorsements permit the application of the Sentire system in a range of minimally invasive surgical procedures across general, gynecological, thoracic, and urological fields.
"This partnership represents a pivotal step towards enhancing the accessibility of robotic surgery globally," stated Professor Kwok Wai Samuel Au, founder and CEO of Cornerstone Robotics. "Despite the soaring demand for minimally invasive surgical techniques, technology availability lags far behind. At Cornerstone, we have harnessed our R&D capabilities across the technological spectrum, allowing us to progress our robotic surgery technology continually. Partnering with Medtronic empowers us to scale up our efforts and reach more surgeons and patients worldwide."
Matt Anderson, Senior Vice President and President of Medtronic’s surgical solutions division said, "This investment and distribution agreement expand Medtronic's capacity to enhance access to minimally invasive surgery for patients globally. We are excited to provide greater choice in robotics, and the Sentire system will complement our Hugo platform effectively."
The partnership signifies a significant milestone for both entities. Cornerstone Robotics, with its robust innovation and commitment to quality, and Medtronic, with its extensive medical expertise and resources, are poised to change the landscape of surgical care. Partners in this initiative, including Kirkland Ellis and Global Law Office for legal matters and Morgan Stanley for financial guidance, underline the strength and commitment to this transformative journey in healthcare.
Cornerstone Robotics envisions a future where high-quality surgical care is not just a capability of the privileged but a standard for patients across all demographics. The collaboration with Medtronic is a vital component of this vision, as both organizations collectively focus on making robotic-assisted surgeries more accessible and beneficial worldwide.
To learn more about Cornerstone Robotics and its pioneering technologies, please visit Cornerstone Robotics or find them on LinkedIn.
The partnership features a substantial investment of approximately $700 million from Medtronic in Cornerstone Robotics, granting Medtronic distribution rights for Cornerstone's revolutionary surgical system, the Sentire™, across select international markets outside the United States where the system is approved. This development is designed to provide more surgical options and improve surgical outcomes for a broader population around the world.
Addressing Global Surgical Needs
Currently, only a minuscule percentage of surgeries around the globe utilize robotic systems. Cornerstone Robotics and Medtronic share a unified vision to decrease this gap significantly by expanding the reach of their innovative surgical solutions to numerous healthcare providers and patients in need. This mission is not only about technological advancement but also about addressing a pressing global health challenge—the accessibility of minimally invasive surgical care.
To achieve this goal, it is essential for both companies to leverage continuous technical innovations and scalable market strategies. Combining Cornerstone's cutting-edge robotics technology with Medtronic's expansive global network positions them uniquely to usher in a new era of high-quality robotic surgery accessible to a larger patient demographic.
Pioneering Surgical Solutions
Cornerstone Robotics has established solid foundations built on extensive research and development, integrating various technological stacks while employing a vertically integrated operational model. The company designs and manufactures essential hardware, control software, advanced algorithms, and proprietary imaging and energy platforms. This meticulous approach allows Cornerstone to maintain significant control over product integration, quality assurance, and supply chain resilience, crucial for the precise operation of the Sentire surgical system in demanding clinical environments.
As of 2024, the Sentire surgical system received approval from the National Medical Products Administration in China. Furthermore, in May 2026, the system attained CE marking status in the European Union and received validation from the Health Sciences Authority in Singapore. These endorsements permit the application of the Sentire system in a range of minimally invasive surgical procedures across general, gynecological, thoracic, and urological fields.
Quotes from Leadership
"This partnership represents a pivotal step towards enhancing the accessibility of robotic surgery globally," stated Professor Kwok Wai Samuel Au, founder and CEO of Cornerstone Robotics. "Despite the soaring demand for minimally invasive surgical techniques, technology availability lags far behind. At Cornerstone, we have harnessed our R&D capabilities across the technological spectrum, allowing us to progress our robotic surgery technology continually. Partnering with Medtronic empowers us to scale up our efforts and reach more surgeons and patients worldwide."
Matt Anderson, Senior Vice President and President of Medtronic’s surgical solutions division said, "This investment and distribution agreement expand Medtronic's capacity to enhance access to minimally invasive surgery for patients globally. We are excited to provide greater choice in robotics, and the Sentire system will complement our Hugo platform effectively."
Importance of Collaboration
The partnership signifies a significant milestone for both entities. Cornerstone Robotics, with its robust innovation and commitment to quality, and Medtronic, with its extensive medical expertise and resources, are poised to change the landscape of surgical care. Partners in this initiative, including Kirkland Ellis and Global Law Office for legal matters and Morgan Stanley for financial guidance, underline the strength and commitment to this transformative journey in healthcare.
Cornerstone Robotics envisions a future where high-quality surgical care is not just a capability of the privileged but a standard for patients across all demographics. The collaboration with Medtronic is a vital component of this vision, as both organizations collectively focus on making robotic-assisted surgeries more accessible and beneficial worldwide.
To learn more about Cornerstone Robotics and its pioneering technologies, please visit Cornerstone Robotics or find them on LinkedIn.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.